Market Watch – Page 564 – Biotech Insider

All Posts in "Market Watch"

Gold loses steam after tapping fresh 6-year highs

Silver futures mark sharpest weekly gain in 3 years

by Editor — July 21, 2019 By Editor in Market Watch

Trump tweets are blowing Fed off course

Trump tweets feed back into market push for lower interest rates

by Editor — July 21, 2019 By Editor in Market Watch

PayPal earnings: Reaping the benefits of investments

Bets on other payments players will give earnings a boost

by Editor — July 20, 2019 By Editor in Market Watch

Facebook earnings seem immune to the Big Tech backlash — for now

Stock near all-time highs despite reported $5 billion fine from FTC, continuing government scrutiny on business and Libra plans

by Editor — July 20, 2019 By Editor in Market Watch

Head of the world’s largest asset manager says taking risk off the table in stocks is a mistake

Change of tone in central bank behavior provides support

by Editor — July 20, 2019 By Editor in Market Watch

Stocks close lower as Fed seen signaling only modest rate cut, Iran seizes tankers

Microsoft shares rally after earnings beat

by Editor — July 20, 2019 By Editor in Market Watch

Silver rallies to its highest in over a year, plays ‘catch up’ to gold’s gains

Silver may make a move toward $20/oz if gold climbs to $1,500 or more: analyst

by Editor — July 19, 2019 By Editor in Market Watch

AMD stock falls after analyst says massive rally is over

Mizuho downgrades AMD with September quarter shipments seen tracking down, stock’s rally seen over

by Editor — July 19, 2019 By Editor in Market Watch

Apple stock gets an upgrade as analyst sees ‘compelling’ reason to buy forthcoming iPhone models

Raymond James says Apple is likely to offer a lower-priced 5G model in 2020, helping drive upgrades.

by Editor — July 19, 2019 By Editor in Market Watch

Stocks snap 2-day skid as Fed’s Williams says central bank should act swiftly to quash slowdown signs

UnitedHealth’s 2.3% stock drop weighs on the Dow.

by Editor — July 19, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.